Home › Funds › AMERICAN CAPITAL MANAGEMENT INC › GMED
AMERICAN CAPITAL MANAGEMENT INC position in GMED
GLOBUS MED INC · Health Care
AMERICAN CAPITAL MANAGEMENT INC reported holding 448,391 shares of GMED (GLOBUS MED INC) in its Q3 2026 13F filing — a position valued at US$33.6M, representing 1.76% of its reported portfolio and ranking #22 among its reported holdings. AMERICAN CAPITAL MANAGEMENT INC has disclosed GMED holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How AMERICAN CAPITAL MANAGEMENT INC's GMED position evolved
AMERICAN CAPITAL MANAGEMENT INC first disclosed a stake in GMED in Q4 2024 at 33,110 shares (US$2.7M). The position peaked in Q1 2026 at 663,049 shares, worth US$57.1M. Across 8 filings, AMERICAN CAPITAL MANAGEMENT INC increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 448,391 shares valued at US$33.6M — a reduction of -204,681 shares quarter over quarter.. Notable position changes include a 790% increase in Q1 2025 (shares fell 19% over the following quarter), a 64% increase in Q2 2025 (shares fell 3% over the following quarter), a 36% increase in Q1 2026 (shares fell 8% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 33.11K | $2.74M | New |
| Q1 2025 | 294.84K | $21.58M | Add |
| Q2 2025 | 483.52K | $28.54M | Add |
| Q3 2025 | 499.06K | $28.58M | Add |
| Q4 2025 | 486.21K | $42.45M | Reduce |
| Q1 2026 | 663.05K | $57.13M | Add |
| Q2 2026 | 653.07K | $51.60M | Reduce |
| Q3 2026 | 448.39K | $33.58M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GMED and 13F data
GMED (GLOBUS MED INC) is a Health Care company. 34 other funds we track also report a position in GMED — the largest reported positions include KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (US$239.4M), Boston Trust Walden Corp (US$123.1M), GW&K Investment Management, LLC (US$110.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GMED
- KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 3.20M sh · $239.44M · Q3 2026
- Boston Trust Walden Corp 1.64M sh · $123.07M · Q3 2026
- GW&K Investment Management, LLC 1.47M sh · $110.29M · Q3 2026
- GENEVA CAPITAL MANAGEMENT LLC 1.25M sh · $93.58M · Q3 2026
- Clark Capital Management Group, Inc. 1.18M sh · $88.22M · Q3 2026
More on AMERICAN CAPITAL MANAGEMENT INC
FAQ
How long has AMERICAN CAPITAL MANAGEMENT INC held GMED?
AMERICAN CAPITAL MANAGEMENT INC has disclosed GMED holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is AMERICAN CAPITAL MANAGEMENT INC's current position in GMED?
As of Q3 2026, AMERICAN CAPITAL MANAGEMENT INC holds 448.39K shares of GMED (GLOBUS MED INC), valued at $33.58M, representing 1.76% of its reported portfolio and ranking #22.
Has AMERICAN CAPITAL MANAGEMENT INC been buying or selling GMED?
In the latest 13F filing (Q3 2026), AMERICAN CAPITAL MANAGEMENT INC reduced its position in GMED. The position peaked in Q1 2026 at 663.05K shares.
Which other funds hold GMED?
Other major institutional holders of GMED include KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, Boston Trust Walden Corp, GW&K Investment Management, LLC, among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.